CMC

47.1

+0.36%↑

FUL

58.1

+1.75%↑

USAU

9.41

+3.98%↑

CMC

47.1

+0.36%↑

FUL

58.1

+1.75%↑

USAU

9.41

+3.98%↑

CMC

47.1

+0.36%↑

FUL

58.1

+1.75%↑

USAU

9.41

+3.98%↑

CMC

47.1

+0.36%↑

FUL

58.1

+1.75%↑

USAU

9.41

+3.98%↑

CMC

47.1

+0.36%↑

FUL

58.1

+1.75%↑

USAU

9.41

+3.98%↑

Search

Ashland Global Holdings Inc

Gesloten

SectorGrondstoffen

57.92 0.31

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

56.48

Max

57.93

Belangrijke statistieken

By Trading Economics

Inkomsten

-181M

-165M

Verkoop

-117M

405M

EPS

0.28

Dividendrendement

2.73

Winstmarge

-40.741

Werknemers

3,200

EBITDA

-223M

-140M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+34.75% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

2.73%

2.80%

Volgende Winsten

29 apr 2025

Volgende dividenddatum

13 jun 2025

Volgende Ex Dividend datum

30 mei 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

2.8B

Vorige openingsprijs

57.61

Vorige sluitingsprijs

57.92

Nieuwssentiment

By Acuity

50%

50%

89 / 170 Rangschikking in Basic materials

Technische score

By Trading Central

Vertrouwen

Strong Bullish Evidence

Ashland Global Holdings Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

17 mrt 2025, 11:00 UTC

Acquisities, Fusies, Overnames

Ashland Completes Sale of Avoca Business to Mane

28 jan 2025, 22:05 UTC

Winsten

Ashland 1Q Adj EPS 28c >ASH

28 jan 2025, 22:04 UTC

Winsten

Ashland Backs FY25 Sales $1.9B-$2.05B >ASH

28 jan 2025, 22:04 UTC

Winsten

Ashland 1Q Sales $405M >ASH

28 jan 2025, 22:04 UTC

Winsten

Ashland 1Q Cont Ops Loss/Shr $3.51 >ASH

28 jan 2025, 22:03 UTC

Winsten

Ashland 1Q Loss/Shr $3.50 >ASH

6 nov 2024, 22:07 UTC

Winsten

Ashland 4Q EPS 39c >ASH

6 nov 2024, 22:07 UTC

Winsten

Ashland 4Q Sales $522M >ASH

6 nov 2024, 22:07 UTC

Winsten

Ashland Sees FY25 Sales $1.90B-$2.05B >ASH

3 sep 2024, 11:00 UTC

Acquisities, Fusies, Overnames

Ashland Completes Sale of Nutraceuticals Business to Affil of Turnspire Capital Partners >ASH

6 aug 2024, 21:04 UTC

Winsten

Ashland Sees FY Sales $2.1B >ASH

6 aug 2024, 21:03 UTC

Winsten

Ashland Sees 4Q Sales $530M-$540M >ASH

6 aug 2024, 21:03 UTC

Winsten

Ashland 3Q Adj EPS $1.49 >ASH

6 aug 2024, 21:02 UTC

Winsten

Ashland 3Q Sales $544M >ASH

6 aug 2024, 21:02 UTC

Winsten

Ashland 3Q Cont Ops EPS 60c >ASH

6 aug 2024, 21:02 UTC

Winsten

Ashland 3Q EPS 12c >ASH

6 aug 2024, 21:02 UTC

Winsten

Ashland Issues Outlook for 4Q and Full-Yr Fiscal 2024

7 mei 2024, 11:01 UTC

Acquisities, Fusies, Overnames

Ashland: Transaction Is Expected to Close in 3Q >ASH

7 mei 2024, 10:59 UTC

Acquisities, Fusies, Overnames

Ashland Signs Definitive Agreement to Sell Nutraceuticals Business to Turnspire Capital Partners >ASH

Peer Vergelijking

Prijswijziging

Ashland Global Holdings Inc Prognose

Koersdoel

By TipRanks

34.75% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 77.86 USD  34.75%

Hoogste 93 USD

Laagste 68 USD

Gebaseerd op 8 Wall Street-analisten die 12-maands prijsdoelen bieden voor Ashland Global Holdings Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

8 ratings

5

Buy

3

Hold

0

Sell

Technische score

By Trading Central

56.33 / 59.72Steun & Weerstand

Korte Termijn

Strong Bullish Evidence

Gemiddeld Termijn

Weak Bearish Evidence

Lange Termijn

Weak Bearish Evidence

Sentiment

By Acuity

89 / 170 Rangschikking in Grondstoffen

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Ashland Global Holdings Inc

Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.